IDEXX Laboratories Inc (IDXX) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.
Total Revenue Chart for IDEXX Laboratories Inc
IDEXX Laboratories Inc (IDXX) revenue for FY2025 was USD 4.3B, a 10.4% change from FY2024. IDEXX Laboratories Inc's revenue grew from USD 30.5M in 1991 to USD 4.3B in 2025 (14010.5% over 34 years). Earnings per share grew from USD 0.25 in 2000 to USD 8.03 in 2022 (3062.5%). Revenue compound annual growth rate: 5-year CAGR of 9.7%, 10-year CAGR of 10.4%, 20-year CAGR of 10.0%.
Total Revenue (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $46.54B
- Implied Share Price
- $590.00
- Enterprise Value
- $47.30B
- Revenue (TTM)
- $4.55B
- EBITDA
- $1.62B
- Profit Margin
- 25.03%
- Trailing P/E
- 41.14
- Forward P/E
- 39.84
- Price/Book (MRQ)
- 29.81
- Price/Sales (TTM)
- 10.21
- EV/EBITDA
- 30.37
- EV/Revenue
- 10.64
- Dividend Yield
- —
- Book Value
- $19.64
- Free Cash Flow (FY2025)
- $1.05B
- Free Cash Flow Yield
- 2.26%
Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.